ConductScience.org, home

Paper41900860

Tranexamic Acid for Reduction of Blood Loss in Patients with Extracapsular Proximal Femur Fractures: Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Ilic I and 3 others. Pharmaceutics, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Tranexamic Acid for Reduction of Blood Loss in Patients with Extracapsular Proximal Femur Fractures: Systematic Review and Meta-Analysis of Randomized Clinical Trials. Papers, record 41900860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41900860

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tranexamic Acid for Reduction of Blood Loss in Patients with Extracapsular Proximal Femur Fractures: Systematic Review and Meta-Analysis of Randomized Clinical Trials.
PubMed
Journal
Pharmaceutics
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ilic IIrenahttps://orcid.org/0000-0001-5347-3264
2Stojadinovic IIvan
3Ristic BBranko
4Ilic MMilenahttps://orcid.org/0000-0003-3229-4990

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137888081Rate of Complications after Hip Fractures Caused by Prolonged Time-to-Surgery Depends on the Patient's Individual Type of Fracture and Its Treatment.J Pers Med2023https://conductscience.org/library/papers/37888081PubMed
232291982[Application of intravenous injection of tranexamic acid combined with local use of tranexamic acid cocktail in intertrochanteric fracture fixation].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi2020https://conductscience.org/library/papers/32291982PubMed
330882622Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: A meta-analysis.Medicine (Baltimore)2019https://conductscience.org/library/papers/30882622PubMed
433641430Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.Bone Joint J2021https://conductscience.org/library/papers/33641430PubMed
522168590Liberal or restrictive transfusion in high-risk patients after hip surgery.N Engl J Med2011https://conductscience.org/library/papers/22168590PubMed
637118993Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality.J Bone Miner Res2023https://conductscience.org/library/papers/37118993PubMed
730967695
Efficacy and Safety of Tranexamic Acid for Controlling Bleeding During Surgical Treatment of Intertrochanteric Fragility Fracture with Proximal Femoral Nail Anti-rotation: A Randomized Controlled Trial.
Indian J Orthop2019https://conductscience.org/library/papers/30967695PubMed
824691607Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.JAMA2014https://conductscience.org/library/papers/24691607PubMed
929426608The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA.Injury2018https://conductscience.org/library/papers/29426608PubMed
1038205755Effectiveness and safeties of hemocoagulase and tranexamic acid to reduce perioperative blood loss in intertrochanteric fracture PFNA fixation.Acta Orthop Belg2023https://conductscience.org/library/papers/38205755PubMed
1140192873Efficacy and safety of Tranexamic acid use on postoperative blood transfusion in hip fracture patients- a systematic review and meta-analysis.Eur J Trauma Emerg Surg2025https://conductscience.org/library/papers/40192873PubMed
1231902124The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.J Thromb Thrombolysis2020https://conductscience.org/library/papers/31902124PubMed
1338875178Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Management in Intertrochanteric Fractures: A Randomized Controlled Study.Med Sci Monit2024https://conductscience.org/library/papers/38875178PubMed
143802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
1534689986Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.Injury2022https://conductscience.org/library/papers/34689986PubMed
1633536047Early intravenous tranexamic acid intervention reduces post-traumatic hidden blood loss in elderly patients with intertrochanteric fracture: a randomized controlled trial.J Orthop Surg Res2021https://conductscience.org/library/papers/33536047PubMed
1716720744Anemia in old age is associated with increased mortality and hospitalization.J Gerontol A Biol Sci Med Sci2006https://conductscience.org/library/papers/16720744PubMed
1832415365Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial.Eur J Trauma Emerg Surg2022https://conductscience.org/library/papers/32415365PubMed
1929929380Efficacy and Safety of Tranexamic Acid for Blood Salvage in Intertrochanteric Fracture Surgery: A Meta-Analysis.Clin Appl Thromb Hemost2018https://conductscience.org/library/papers/29929380PubMed
2036282170A single dose of tranexamic acid infusion is safe and effective to reduce total blood loss during proximal femoral nailing for intertrochanteric fractures: A prospective randomized study.Ulus Travma Acil Cerrahi Derg2022https://conductscience.org/library/papers/36282170PubMed

See all 65 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42795921Efficacy of Tranexamic Acid in a Large Population with Proximal Femur Fractures-A Matched Pair Study of 7394 Patients from the Registry for Geriatric Trauma (ATR-DGU).J Clin Med2026https://conductscience.org/library/papers/42795921

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41900860

GET https://conductscience.org/api/papers/v1/41900860/references?page=2